Accumulation of annexin A2 and S100A10 prevents apoptosis of apically delaminated, transformed epithelial cells
Open Access
- 16 October 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (43)
Abstract
In various epithelial tissues, the epithelial monolayer acts as a barrier. To fulfill its function, the structural integrity of the epithelium is tightly controlled. When normal epithelial cells detach from the basal substratum and delaminate into the apical lumen, the apically extruded cells undergo apoptosis, which is termed anoikis. In contrast, transformed cells often become resistant to anoikis and able to survive and grow in the apical luminal space, leading to the formation of multilayered structures, which can be observed at the early stage of carcinogenesis. However, the underlying molecular mechanisms still remain elusive. In this study, we first demonstrate that S100A10 and ANXA2 (Annexin A2) accumulate in apically extruded, transformed cells in both various cell culture systems and murine epithelial tissues in vivo. ANXA2 acts upstream of S100A10 accumulation. Knockdown of ANXA2 promotes apoptosis of apically extruded RasV12-transformed cells and suppresses the formation of multilayered epithelia. In addition, the intracellular reactive oxygen species (ROS) are elevated in apically extruded RasV12 cells. Treatment with ROS scavenger Trolox reduces the occurrence of apoptosis of apically extruded ANXA2-knockdown RasV12 cells and restores the formation of multilayered epithelia. Furthermore, ROS-mediated p38MAPK activation is observed in apically delaminated RasV12 cells, and ANXA2 knockdown further enhances the p38MAPK activity. Moreover, the p38MAPK inhibitor promotes the formation of multilayered epithelia of ANXA2-knockdown RasV12 cells. These results indicate that accumulated ANXA2 diminishes the ROS-mediated p38MAPK activation in apically extruded transformed cells, thereby blocking the induction of apoptosis. Hence, ANXA2 can be a potential therapeutic target to prevent multilayered, precancerous lesions.Keywords
Funding Information
- Japan Society for the Promotion of Science London (21H05285A01)
- Japan Society for the Promotion of Science London (21H05039)
- Japan Society for the Promotion of Science London (JPJSBP1 20215703)
- MEXT | JST | Moonshot Research and Development Program (JPMJPS2022)
- Japan Society for the Promotion of Science London (20K07630)
This publication has 51 references indexed in Scilit:
- Genotoxic Agents Promote the Nuclear Accumulation of Annexin A2: Role of Annexin A2 in Mitigating DNA DamagePLOS ONE, 2012
- Crowding induces live cell extrusion to maintain homeostatic cell numbers in epitheliaNature, 2012
- Live-cell delamination counterbalances epithelial growth to limit tissue overcrowdingNature, 2012
- S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cellsProteome Science, 2011
- Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachmentNature, 2009
- Characterization of the interface between normal and transformed epithelial cellsNature Cell Biology, 2009
- Oncogenic K-Ras Regulates Proliferation and Cell Junctions in Lung Epithelial Cells through Induction of Cyclooxygenase-2 and Activation of Metalloproteinase-9Molecular Biology of the Cell, 2009
- Anoikis mechanismsCurrent Opinion in Cell Biology, 2001
- Annexin II tetramer: structure and functionMolecular and Cellular Biochemistry, 1995
- Disruption of epithelial cell-matrix interactions induces apoptosisJournal of Cell Biology, 1994